High-dose-rate brachytherapy for early breast cancer: An ambulatory technique

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 1, 1999, Pages 85-90

  Hennequin, Christophe ^a   Durdux, Catherine ^b   Espié, Marc ^a   Balla Mekias, Saïda ^a   Housset, Martin ^b   Marty, Michel ^a   Chotin, Gisèle ^a   Maylin, Claude ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL TENON   (France)

Author keywords

Breast cancer; Conservative treatment; Cosmetic result; High dose rate brachytherapy; Local control

Indexed keywords

IRIDIUM;

ADULT; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PARTIAL MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TUMOR VOLUME;

ADULT; AGED; AMBULATORY CARE; ANALYSIS OF VARIANCE; BRACHYTHERAPY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; ESTHETICS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE;

EID: 0032813962     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00139-X     Document Type: Article

References (26)

1. Effects of radiotherapy and surgery in early breast cancer An overview of the randomized trials . N Engl J Med. 333:1995;1444-1455.
2. Romestaing P., Lehingue Y., Carrie C., Coquard R., Montbarbon X., Ardiet J.-M., Mamelle N., Gérard J.-P. Role of a 10 Gy boost in the conservative treatment of early breast cancer Results of a randomized clinical trial in Lyon, France . J Clin Oncol. 15:1997;963-968.
3. Fourquet A., Campana F., Mosseri V., Cetingoz R., Luciani S., Labib A., Asselain B., Vilcoq J.R. Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone Final results of a randomized trial . Radiother Oncol. 34:1995;114-120.
4. Perez C.A., Taylor M.E., Halverson K., Garcia D., Kuske R.R., Lockett M.A. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast A nonrandomized comparison . Int J Radiat Oncol Biol Phys. 34:1996;995-1007.
5. Touboul E., Belkacemi Y., Lefranc J., Uzan S., Ozsahin M., Korbas D., Buffat L., Balosso J., Pene F., Blondon J., Schlienger M., Laugier A. Early breast cancer Influence of the type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy . Radiother Oncol. 34:1995;105-113.
6. Van Limbergen E., Rijnders A., van der Schueren E., Lerut T., Christiaens R. Cosmetic evaluation of breast conserving treatment for mammary cancer 2 A quantitative analysis of radiation dose, fractionation schedules, and surgical treatment techniques on cosmetic results . Radiother Oncol. 16:1989;253-267.
7. Vicini F.A., Horwitz E.M., Lacerna M.D., Dmuchowski C.F., Brown D.M., White J., Chen P.Y., Edmundson G.K., Gustafson G.S., Clarke D.H., Gustafson G.S., Matter R.C., Martinez A.C. Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 37:1997;845-852.
8. Hammer J., Seewald D., Track C., Zoidl J., Labeck W. Breast cancer Primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation . Radiology. 193:1994;573-577.
9. Jacobs H. Breast conserving therapy: Experience with HDR afterloading iridium-192 implants. In: Martinez AA, Orton CG, Mould RF, editors. Brachytherapy HDR and LDR. Columbia, MD; Nucletron Corporation; 1990. 251-256.
10. Pierquin B., Dutreix A., Paine C.H., Chassagne D., Marinello G., Ash D. The Paris system in interstitial radiation therapy. Acta Radiologica. 17:1978;33-48.
11. LENT-SOMA tables. Radiother Oncol. 35:1995;17-60.
12. LENT-SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 31:1995;1049-1091.
13. Chastagnol N, Hennequin C, Bettahar R, Mekias S, Salemkour A, Chotin G, Hubert F, Maylin C. Cost comparison between low dose-rate (LDR) and high dose-rate (HDR) brachytherapy in breast cancer: Annual brachytherapy meeting, GEC-ESTRO, Stockholm, 5-7 May. Radiother Oncol 1997;43(Suppl. 1):S11(Abstr. 38).
14. Bentzen S., Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol. 20:1991;159-165.
15. Turesson I., Thames H. Repair capacity anf kinetics of human skin during fractionated radiotherapy Erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up . Radiother Oncol. 15:1996;169-188.
16. Withers H.R., Thames H.D., Peters L.J. A new isoeffect curve for change in dose per fraction. Radiother Oncol. 1:1983;187-191.
17. Harris JR, Morrow M. Treatment of early-stage breast cancer. In: Harris JR; et al. Diseases of the breast. Philadelphia: Lippincott-Raven; 1996.
18. Machtay M., Lanciano R., Hoffman J., Hanks G. Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma. Int J Radiat Oncol Biol Phys. 30:1994;43-48.
19. Sedlmayer F., Rahim H., Kogelnik H., Menzel C., Merz F., Deutschmann H., Kranzinger M. Quality assurance in breast cancer brachytherapy Geographic miss in the interstitial boost treatment of the tumor bed . Int J Radiat Oncol Biol Phys. 34:1996;1133-1139.
20. Clarke D., Lê M., Sarrazin D., Lacombe M., Fontaine F., Travagli J., May-Levin F., Contesso G., Arriagada R. Analysis of local-regional relapse in patients with early breast cancers treated by excision and radiotherapy Experience of the Institut Gustave Roussy . Int J Radiat Oncol Biol Phys. 11:1985;137-145.
21. Kurtz J., Jacquemier J., Amalric R., Brandone H., Ayme Y., Hans D., Bressac C., Roth J., Spitalier J. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 65:1990;1867-1878.
22. Locker A., Ellis I., Morgan D., Elston C., Mitchell A., Blamey R. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg. 76:1989;890-894.
23. Shiliang S., Jiaxang Y., Jian L., Xinshen T., Yongmei P., Qian X. Breast conservative therapy in Chonking (China) A preliminary report on high-dose-rate afterloading iridium-192 implants . Bull Cancer/Radioth. 79:1992;169-171.
24. Olivotto I., Rose M., Osteen R., Love S., Cady B., Silver B., Recht A., Harris J. Late cosmetic outcome after conservative surgery and radiotherapy Analysis of causes of cosmetic failure . Int J Radiat Oncol Biol Phys. 17:1989;747-753.
25. Taylor M.E., Perez C.A., Halverson K.J., Kuske R.R., Philpott G.W., Garcia D.M., Mortimer J.E., Myerson R.J., Radford D., Rush C. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 31:1995;753-764.
26. Wazer D., Dipetrillo T., Schmidt-Ullrich R., Weld L., Smith T., Marchant D., Robert N. Factors influencing cosmetic outcome and complications risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 10:1992;356-363.